Limited-Time September Offer: Try 7 Days for Free

Humacyte (HUMA) Stock Price

$1.47 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    6
  • Fundamental

    1
  • Technical

    2

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Humacyte, AI stock picks, stock alerts and much more.

Sign up

HUMA AI Stock Analysis

AI stock analysis for HUMA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Humacyte (HUMA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Humacyte (HUMA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Humacyte (HUMA), currently trading at $1.47, will... Sign up to access price prediction.

About HUMA

LSE

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$19.97
1.4%
8
INO Inovio Pharmaceuticals
INO
$2.38
10.2%
2
MRNA Moderna
MRNA
$23.51
7.4%
4
AVXL Anavex Life Sciences
AVXL
$9.37
2.2%
5
BBIO BridgeBio Pharma
BBIO
$51.21
2.6%
6

HUMA Alternative Data

Web Traffic

Humacyte receives an estimated 6946 monthly visitors to humacyte.com, which is down by -68% over the last month.

  • Web Traffic

    6946

  • Change from Previous Month

    68%

  • 3 Month Change

    26.9%

  • YoY Change

    26.9%

Twitter Followers

Humacyte has 2,345 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.8% over the last month.

  • Twitter Followers

    2345

  • Daily Change

    0%

  • 1 Month Change

    1.8%

  • 3 Month Change

    6.2%

  • YoY Change

    6.2%

Facebook Engagement

Humacyte has engaged 17 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    17

  • Daily Change

    0%

  • 1 Month Change

    183.3%

  • 3 Month Change

    10.5%

  • YoY Change

    10.5%

Youtube Subscribers

Humacyte has 412 subscribers on its main Youtube channel, down by -0.2% over the last month.

  • Youtube Subscribers

    412

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    1.2%

  • YoY Change

    1.2%

LinkedIn Followers

14,322 are following Humacyte on LinkedIn, up by 1.8% over the last month.

  • LinkedIn Followers

    14322

  • Daily Change

    0%

  • 1 Month Change

    1.8%

  • 3 Month Change

    4.6%

  • YoY Change

    4.6%

Job Postings

Humacyte currenly has an estimated 13 open job postings, up by 116.7% over the last month.

  • Job Postings

    13

  • Daily Change

    0%

  • 1 Month Change

    116.7%

  • 3 Month Change

    1200%

  • YoY Change

    1200%

LinkedIn Employees

According to LinkedIn, Humacyte has 192 employees, down by -2.5% over the last month.

  • LinkedIn Employees

    192

  • Daily Change

    0%

  • 1 Month Change

    2.5%

  • 3 Month Change

    2.5%

  • YoY Change

    2.5%

Reddit Mentions

Humacyte has been mentioned an estimated 3 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    3

  • Daily Change

    50%

  • 1 Month Change

    0%

  • 3 Month Change

    200%

Business Outlook

According to employee reviews, the business outlook among employees at Humacyte is 63 out of 100 (bullish).

  • Business Outlook

    63

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Humacyte was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

HUMA Financials

HUMA Key Metrics
  • Total Revenue

    $7.2M

  • Net Income

    $127.8M

  • Earnings per Share

    $1.08

  • Free cash flow

    -$26.6M

  • EBITDA

    $104.5M

  • EBITDA Ratio

    14.4634

  • Total Assets

    $137.9M

HUMA 2-year Revenue & Income
HUMA 2-year Free Cash Flow

HUMA Technicals

HUMA SMA
HUMA RSI

FAQ

What's the current price of Humacyte (HUMA) Stock?
The price of an Humacyte (HUMA) share is $1.47.

What's the market cap of Humacyte?
The current market cap of Humacyte is 232.8M.

What are some stocks similar to Humacyte (HUMA) that investors often compare it to?
Humacyte (HUMA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Humacyte's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Humacyte's stock price to be around $1.47 in 2026. Starting from the current price of $1.47, this represents a 0.3% change in price, indicating a neutral outlook for the stock.

How to buy Humacyte (HUMA) Stock?
Humacyte stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Humacyte shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.